AbbVie Other Aesthetics — Net revenues increased by 5.6% to $320.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 3.6%, from $332.00M to $320.00M. Over 4 years (FY 2021 to FY 2025), Other Aesthetics — Net revenues shows a downward trend with a -3.6% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates successful market penetration or expansion of the secondary aesthetic product portfolio, while a decrease may suggest market saturation or shifting consumer preferences away from these specific treatments.
This metric represents the total net sales generated from the company's secondary portfolio of aesthetic products, exclu...
Peers in the medical aesthetics and dermatology space typically report this as a sub-segment of their broader aesthetics or consumer health divisions, often categorized as 'other' or 'emerging' product lines.
abbv_segment_other_aesthetics_net_revenues| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $422.00M | $352.00M | $349.00M | $323.00M | $332.00M | $312.00M | $323.00M | $286.00M | $331.00M | $298.00M | $319.00M | $319.00M | $318.00M | $310.00M | $332.00M | $315.00M | $327.00M | $303.00M | $320.00M |
| QoQ Change | — | -16.6% | -0.9% | -7.4% | +2.8% | -6.0% | +3.5% | -11.5% | +15.7% | -10.0% | +7.0% | +0.0% | -0.3% | -2.5% | +7.1% | -5.1% | +3.8% | -7.3% | +5.6% |
| YoY Change | — | — | — | — | -21.3% | -11.4% | -7.4% | -11.5% | -0.3% | -4.5% | -1.2% | +11.5% | -3.9% | +4.0% | +4.1% | -1.3% | +2.8% | -2.3% | -3.6% |
We use cookies for analytics. See our Privacy and Cookie Policy.